Abstract The Global Burden of Disease Study (GBD) began 30 years ago with the goal of
providing timely, valid and relevant assessments of critical health outcomes. Over this …

Background Understanding the level and characteristics of protection from past SARS-CoV-
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …

Background Nirmatrelvir–ritonavir has been authorized for emergency use by many
countries for the treatment of coronavirus disease 2019 (Covid-19). However, the supply …

Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the …

Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that …

The largest burden of COVID-19 is carried by the elderly, and persons living in nursing
homes are particularly vulnerable. However, 94% of the global population is younger than …

Background Regular, detailed reporting on population health by underlying cause of death
is fundamental for public health decision making. Cause-specific estimates of mortality and …

Background Detailed, comprehensive, and timely reporting on population health by
underlying causes of disability and premature death is crucial to understanding and …

The omicron variant is thought to cause less olfactory dysfunction than previous variants of
SARS-CoV-2, but the reported prevalence differs greatly between populations and studies …

Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …